tmdx: the income statement

MyFinsight

TransMedics Group, Inc. (TMDX)

For the quarter ending 2025-06-30, TMDX made $157,370K in revenue. $34,907K in net income. Net profit margin of 22.18%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30
Total revenue	157,370	143,537	108,761
Service	41,360	-	-
Product	19,421	-	-
Total cost of revenue	60,781	55,309	47,916
Gross profit	96,589	88,228	60,845
Selling, general and administrative	44,088	43,625	42,656
Research, development and clinical trials	15,934	17,160	14,266
Total operating expenses	60,022	60,785	56,922
Income from operations	36,567	27,443	3,923
Interest expense	3,476	3,461	3,617
Interest income and other income (expense)	3,091	2,694	3,939
Total other expense, net	-385	-767	322
Income before income taxes	36,182	26,676	4,245
(provision) benefit for income taxes	1,275	994	-
Current income tax expense (benefit)	-	-	29
Net income	34,907	25,682	4,216

Earnings per share, basic, total	1.03	0.76	0.13
Earnings per share, diluted, total	0.92	0.7	0.12
Weighted average common shares outstanding, diluted	40,558,953	39,914,487	35,683,952
Weighted average number of shares outstanding, basic, total	33,912,669	33,721,603	33,441,394

Unit: Thousand (K) dollars (except for numbers of shares and EPS)